Regeneron expands in gene editing with Mammoth deal

cafead

Administrator
Staff member
  • cafead   Apr 25, 2024 at 11:42: AM
via The five-and-a-half year partnership will give CRISPR drug developer Mammoth $100 million in equity and upfront cash.

article source